Professor Mojisola Adeyeye, Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), has stated that the clearance procedure for the R21/Matrix-M malaria vaccine needed more clinical trials before its full use. Adeyeye stated on a Wednesday program that improvement in a country’s governance is a role in the persistence of … Continue reading Malaria Vaccine: NAFDAC To Conduct Clinical Trials